EyePoint Pharmaceuticals
EYPT
#5226
Rank
โ‚น132.92 B
Marketcap
โ‚น1,606
Share price
0.45%
Change (1 day)
114.28%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น18.03 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has โ‚น18.03 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

EyePoint Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น28.86 B30.2%
2023-12-31$โ‚น22.17 B178.03%
2022-12-31$โ‚น7.97 B-41.89%
2021-12-31$โ‚น13.72 B912.08%
2020-12-31$โ‚น1.35 B128.27%
2019-12-31$โ‚น0.59 B
2018-06-30$โ‚น0.79 B-7.18%
2017-06-30$โ‚น0.86 B-38.86%
2016-06-30$โ‚น1.40 B-5.15%
2015-06-30$โ‚น1.48 B66.03%
2014-06-30$โ‚น0.89 B95.26%
2013-06-30$โ‚น0.45 B-39.45%
2012-06-30$โ‚น0.75 B-54.65%
2011-06-30$โ‚น1.66 B8.86%
2010-06-30$โ‚น1.53 B36.13%
2009-06-30$โ‚น1.12 B-12.74%
2008-06-30$โ‚น1.29 B-61.88%
2007-06-30$โ‚น3.38 B-43.77%
2006-06-30$โ‚น6.02 B128.75%
2005-06-30$โ‚น2.63 B115.32%
2004-06-30$โ‚น1.22 B523.26%
2003-06-30$โ‚น0.19 B
2001-06-30$โ‚น0.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NRC Health
NRC
โ‚น1.28 B-92.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-โ‚น0.26 Billion-101.44% Bahamas